Stockreport

ADC Therapeutics updates data from Phase 1b trial of Zynlonta in lymphoma [Yahoo! Finance]

ADC Therapeutics SA Common Shares  (ADCT) 
PDF ADC Therapeutics updates data from Phase 1b trial of Zynlonta in lymphoma [Read more]